Tremfya 200 mg concentrate for solution for infusion | medicines.ie

Company: Janssen Sciences Ireland (a Johnson & Johnson Company)
Active Ingredient: Guselkumab
Dosage Form: Concentrate for solution for infusion
Legal Category: –
Date of revision: 03/2026

*Additional information is available within the SPC or upon request to the company

Licence numbers with strength, ATC code and dosage form
Licence number	Strength	ATC Code	Dosage Form
EU/1/17/1234/005	200 mg	L04AC16, L04AC	Concentrate for solution for infusion

Licence number: EU/1/17/1234/005
Strength: 200 mg
ATC Code: L04AC16, L04AC
Dosage Form: Concentrate for solution for infusion

Janssen Sciences Ireland (a Johnson & Johnson Company)

Janssen Sciences Ireland UC, Barnahely, Ringaskiddy, IRL - Co. Cork P43 FA46, P43 FA46 Ringaskiddy

Website: https://innovativemedicine.jnj.com/ireland/
Telephone: +3531800709122
Email: medinfo@its.jnj.com